186 related articles for article (PubMed ID: 9218879)
1. Is a central action of acute antimigraine drugs essential?
Goadsby PJ
Cephalalgia; 1997 Jun; 17 Suppl 17():10-1. PubMed ID: 9218879
[No Abstract] [Full Text] [Related]
2. Measuring central action of acute antimigraine drugs in humans.
Schoenen J
Cephalalgia; 1997 Jun; 17 Suppl 17():12-5; discussion 15-6. PubMed ID: 9218880
[No Abstract] [Full Text] [Related]
3. Efficacy of 5HT in migraine.
Buzzi MG
Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
[No Abstract] [Full Text] [Related]
4. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.
Ferrari MD
Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
Deleu D; Hanssens Y
J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
[TBL] [Abstract][Full Text] [Related]
6. Measuring event-related potentials.
Dixon R
Cephalalgia; 1999 Jul; 19 Suppl 24():29-30; discussion 30-1. PubMed ID: 10526680
[No Abstract] [Full Text] [Related]
7. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Deleu D; Hanssens Y
Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
[TBL] [Abstract][Full Text] [Related]
8. 311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study.
Visser WH; Klein KB; Cox RC; Jones D; Ferrari MD
Neurology; 1996 Feb; 46(2):522-6. PubMed ID: 8614525
[TBL] [Abstract][Full Text] [Related]
9. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
Goldstein D
Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
[No Abstract] [Full Text] [Related]
10. The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.
Cumberbatch MJ; Hill RG; Hargreaves RJ
Eur J Pharmacol; 1998 Nov; 362(1):43-6. PubMed ID: 9865528
[TBL] [Abstract][Full Text] [Related]
11. [Differentiated therapy of migraine attack].
Skoromets AA; Amelin AV; Korenko LA
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):39. PubMed ID: 10629928
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of action of zolmitriptan].
Pascual J
Neurologia; 1998 Oct; 13 Suppl 2():9-15. PubMed ID: 9859690
[TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness of 311C90 in the acute treatment of migraine.
Ferrari MD
Eur Neurol; 1996; 36 Suppl 2():4-7. PubMed ID: 8791025
[TBL] [Abstract][Full Text] [Related]
14. 311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.
Zagami AS
Neurology; 1997 Mar; 48(3 Suppl 3):S25-8. PubMed ID: 9071267
[TBL] [Abstract][Full Text] [Related]
15. Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine.
MacLennan SJ; Cambridge D; Whiting MV; Marston C; Martin GR
Eur J Pharmacol; 1998 Nov; 361(2-3):191-7. PubMed ID: 9865508
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
[TBL] [Abstract][Full Text] [Related]
17. Zolmitriptan receives migraine indication.
Am J Health Syst Pharm; 1998 Jan; 55(2):110, 113. PubMed ID: 9465973
[No Abstract] [Full Text] [Related]
18. Zolmitriptan. Introduction.
Mathew N
Cephalalgia; 1997 Oct; 17 Suppl 18():1-3. PubMed ID: 9399011
[No Abstract] [Full Text] [Related]
19. Clinical applications of zolmitriptan (Zomig, 311C90).
Lipton RB; Stewart WF
Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
[TBL] [Abstract][Full Text] [Related]
20. [Zolmitriptan].
Le Jeunne C
Presse Med; 1999 Sep; 28(28):1525-6. PubMed ID: 10526561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
